An early clinical study shows that a new oral drug is safe and well-tolerated in patients with chronic heart failure.

Heart failure remains a substantial cause of morbidity and mortality. Despite numerous therapeutic advancements over the past decade, there are populations in whom therapy is insufficient, ...

Current evidence indicates that nearly 1 in 4 women 20-44 years of age currently has some type of cardiovascular disease, and heart disease is now one of the leading causes of pregnancy-related death ...

The cardioprotective effects of heart failure treatments in patients with cancer were demonstrated today in a presentation at ...

NT-proBNP is one of the most widely used tested biomarkers in medicine. Doctors rely on it to diagnose and monitor heart ...

Accurately measuring electrical signals and calcium levels in the heart can lead to earlier treatment of potentially fatal conditions, such as heart attack or congestive heart failure. Calcium plays ...

Researchers at the Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, and the University of Utah School of Medicine, have demonstrated that a gene therapy can ...

After a diagnosis at 37, one woman lived with severe heart failure for 15 years. She became the first person in Georgia to ...

Diastolic heart failure means there’s a problem with your heart’s ability to fill with blood. It’s a type of congestive heart failure where your heart cannot work efficiently, leading to fluid ...

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...

KUWAIT: The Sabah Al-Ahmad Heart Center, in cooperation with the Kuwait Heart Association, has concluded the Third Heart Failure Conference, bringing together cardiologists, consultants and healthcare ...